Equillium (EQ) Shares Issued (2017 - 2026)
Equillium (EQ) posted quarterly Shares Issued of $14.3 million for Q1 2026, up 138.05% year-over-year from $6.0 million in Q1 2025, and up 37.42% quarter-over-quarter from $10.4 million in Q4 2025.
Equillium (EQ) Shares Issued (2017 - 2026) Analysis & Trends
Equillium (EQ) has reported Shares Issued for 10 consecutive years, with $14.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 138.05% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (up 138.05% YoY), while the FY2025 annual figure was $10.4 million, up 15.41% from the prior year.
- Shares Issued climbed to $14.3 million in Q1 2026 per EQ's latest filing, from $10.4 million in the prior quarter.
- Across five years, Shares Issued topped out at $14.3 million in Q1 2026 and bottomed at $1.9 million in Q1 2022.
- Historically, Shares Issued has averaged $6.8 million across 5 years, with a median of $6.6 million in 2023.
- On a YoY basis, Shares Issued climbed as much as 11729.14% in 2022 and fell as far as 46.66% in 2022.
- Equillium's Shares Issued stood at $5.1 million in 2022, then soared by 37.8% to $7.0 million in 2023, then grew by 28.34% to $9.0 million in 2024, then climbed by 15.41% to $10.4 million in 2025, then surged by 37.42% to $14.3 million in 2026.
- Business Quant data shows EQ's Shares Issued at $14.3 million in Q1 2026, $10.4 million in Q4 2025, and $11.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | 15.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.46 Mn |
| Jun 30, 2026 | 15.46 Mn |
| Mar 31, 2026 | 14.31 Mn |
| Mar 31, 2026 | 14.31 Mn |
| Dec 31, 2025 | 10.41 Mn |
| Dec 31, 2025 | 10.41 Mn |
| Sep 30, 2025 | 11.28 Mn |
| Sep 30, 2025 | 11.28 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Dec 31, 2024 | 9.02 Mn |
| Sep 30, 2024 | 5.15 Mn |
| Sep 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 9.05 Mn |
| Mar 31, 2024 | 9.05 Mn |